FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045987573> ?p ?o ?g. }

• W2045987573 endingPage "421" @default.
• W2045987573 startingPage "412" @default.
• W2045987573 abstract "There is a clinical need for new oral anticoagulants to prevent and treat thromboembolic diseases. Given its integral role in the coagulation cascade, factor Xa is a particularly promising target for new anticoagulation therapies. The aim of this study was to investigate the safety, pharmacodynamics, and pharmacokinetics of BAY 59--7939, an oral, direct factor Xa inhibitor.This single-center, randomized, single-blinded, placebo-controlled, dose-escalation study included 108 healthy white male subjects aged 19 to 45 years. Subjects received single oral doses of either BAY 59--7939 (1.25--80 mg) or placebo; in addition, 1 group received 2 doses of BAY 59--7939 (5--mg tablet and oral solution) or placebo in a crossover design.Oral BAY 59--7939 in single doses up to 80 mg was safe and well tolerated and was not associated with an increased risk of bleeding compared with placebo. Pharmacodynamic effects (inhibition of factor Xa activity, prothrombin time, activated partial thromboplastin time, and Hep Test) and plasma concentration profiles were dose-dependent. Maximum inhibition of factor Xa activity was achieved 1 to 4 hours after administration of BAY 59--7939 and ranged from 20% to 61% for the 5- to 80-mg doses. BAY 59--7939 selectively inhibited factor Xa activity; thrombin (factor IIa) and antithrombin were unaffected. Inhibition of factor Xa activity and prolongation of prothrombin time correlated well with BAY 59--7939 plasma concentrations (r=0.949 and 0.935, respectively).BAY 59--7939 was well tolerated with predictable pharmacodynamics and pharmacokinetics across a wide range of doses in healthy male subjects. BAY 59--7939 was shown to be an effective and specific factor Xa inhibitor." @default.
• W2045987573 created "2016-06-24" @default.
• W2045987573 creator A5040870075 @default.
• W2045987573 creator A5045234054 @default.
• W2045987573 creator A5048067810 @default.
• W2045987573 creator A5083389196 @default.
• W2045987573 creator A5085514176 @default.
• W2045987573 date "2005-10-01" @default.
• W2045987573 modified "2023-10-14" @default.
• W2045987573 title "Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor" @default.
• W2045987573 cites W142041234 @default.
• W2045987573 cites W1980669153 @default.
• W2045987573 cites W1980998991 @default.
• W2045987573 cites W1990482881 @default.
• W2045987573 cites W1996063108 @default.
• W2045987573 cites W2000130043 @default.
• W2045987573 cites W2002508481 @default.
• W2045987573 cites W2007925965 @default.
• W2045987573 cites W2009888849 @default.
• W2045987573 cites W2022932023 @default.
• W2045987573 cites W2023320697 @default.
• W2045987573 cites W2024723340 @default.
• W2045987573 cites W2027151097 @default.
• W2045987573 cites W2042404064 @default.
• W2045987573 cites W2054169479 @default.
• W2045987573 cites W2072581537 @default.
• W2045987573 cites W2085548132 @default.
• W2045987573 cites W2097677308 @default.
• W2045987573 cites W2123402775 @default.
• W2045987573 cites W2137236165 @default.
• W2045987573 cites W2150567223 @default.
• W2045987573 cites W2153196285 @default.
• W2045987573 cites W2153423854 @default.
• W2045987573 cites W2160840488 @default.
• W2045987573 cites W2283957630 @default.
• W2045987573 cites W2312230349 @default.
• W2045987573 cites W2397563323 @default.
• W2045987573 cites W2428808398 @default.
• W2045987573 cites W2462582031 @default.
• W2045987573 cites W2506210560 @default.
• W2045987573 doi "https://doi.org/10.1016/j.clpt.2005.06.011" @default.
• W2045987573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16198660" @default.
• W2045987573 hasPublicationYear "2005" @default.
• W2045987573 type Work @default.
• W2045987573 sameAs 2045987573 @default.
• W2045987573 citedByCount "572" @default.
• W2045987573 countsByYear W20459875732012 @default.
• W2045987573 countsByYear W20459875732013 @default.
• W2045987573 countsByYear W20459875732014 @default.
• W2045987573 countsByYear W20459875732015 @default.
• W2045987573 countsByYear W20459875732016 @default.
• W2045987573 countsByYear W20459875732017 @default.
• W2045987573 countsByYear W20459875732018 @default.
• W2045987573 countsByYear W20459875732019 @default.
• W2045987573 countsByYear W20459875732020 @default.
• W2045987573 countsByYear W20459875732021 @default.
• W2045987573 countsByYear W20459875732022 @default.
• W2045987573 countsByYear W20459875732023 @default.
• W2045987573 crossrefType "journal-article" @default.
• W2045987573 hasAuthorship W2045987573A5040870075 @default.
• W2045987573 hasAuthorship W2045987573A5045234054 @default.
• W2045987573 hasAuthorship W2045987573A5048067810 @default.
• W2045987573 hasAuthorship W2045987573A5083389196 @default.
• W2045987573 hasAuthorship W2045987573A5085514176 @default.
• W2045987573 hasConcept C111113717 @default.
• W2045987573 hasConcept C112705442 @default.
• W2045987573 hasConcept C126322002 @default.
• W2045987573 hasConcept C142724271 @default.
• W2045987573 hasConcept C204787440 @default.
• W2045987573 hasConcept C27081682 @default.
• W2045987573 hasConcept C2777056448 @default.
• W2045987573 hasConcept C2778261982 @default.
• W2045987573 hasConcept C2778382381 @default.
• W2045987573 hasConcept C2780434524 @default.
• W2045987573 hasConcept C71924100 @default.
• W2045987573 hasConcept C87813604 @default.
• W2045987573 hasConcept C98274493 @default.
• W2045987573 hasConceptScore W2045987573C111113717 @default.
• W2045987573 hasConceptScore W2045987573C112705442 @default.
• W2045987573 hasConceptScore W2045987573C126322002 @default.
• W2045987573 hasConceptScore W2045987573C142724271 @default.
• W2045987573 hasConceptScore W2045987573C204787440 @default.
• W2045987573 hasConceptScore W2045987573C27081682 @default.
• W2045987573 hasConceptScore W2045987573C2777056448 @default.
• W2045987573 hasConceptScore W2045987573C2778261982 @default.
• W2045987573 hasConceptScore W2045987573C2778382381 @default.
• W2045987573 hasConceptScore W2045987573C2780434524 @default.
• W2045987573 hasConceptScore W2045987573C71924100 @default.
• W2045987573 hasConceptScore W2045987573C87813604 @default.
• W2045987573 hasConceptScore W2045987573C98274493 @default.
• W2045987573 hasIssue "4" @default.
• W2045987573 hasLocation W20459875731 @default.
• W2045987573 hasLocation W20459875732 @default.
• W2045987573 hasOpenAccess W2045987573 @default.
• W2045987573 hasPrimaryLocation W20459875731 @default.
• W2045987573 hasRelatedWork W1857288271 @default.
• W2045987573 hasRelatedWork W1972266366 @default.
• W2045987573 hasRelatedWork W2029341269 @default.

• next